These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28340808)

  • 1. Cytotoxic Antibody Detection by Means of Flow-Cytometric Cross-Match.
    Bilgen T; Ata P; Tozkir J; Tozkir H; Titiz MI
    Transplant Proc; 2017 Apr; 49(3):440-444. PubMed ID: 28340808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of cytolytic flow cytometry crossmatch before kidney transplantation.
    Moszkowska G; Zielińska H; Zieliński M; Gołębiewska J; Bzoma B; Sakowska J; Dębska-Ślizień A; Trzonkowski P
    Transpl Immunol; 2021 Oct; 68():101426. PubMed ID: 34111563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Cytotoxic Flow Cytometric Cross Match With Complement Dependent Lymphocytotoxicity and Flow Cytometric Cross Match in Renal Transplant Patients.
    Bilgen T; Canbakan M; Şahin G; Titiz Mİ
    Transplant Proc; 2019 May; 51(4):1021-1023. PubMed ID: 31101163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
    Saw CL; Bray RA; Gebel HM
    Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
    Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation.
    Contreras AG; Casillas-Abundis A; Alberú J; Llorente L; Lima G; Arvizu A; de Santiago A; Vilatobá M; Granados J; Morales-Buenrostro LE; Cruz R; Arreola-Guerra JM
    Transpl Immunol; 2018 Oct; 50():8-14. PubMed ID: 29885443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
    Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
    Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
    Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of a flow cytometry cross-match in the setting of a negative complement-dependent cytotoxicity cross-match in heart transplant recipients.
    Keeshan BC; O'Connor MJ; Lin KY; Monos D; Lind C; Mascio CE; Rame JE; Spray TL; Shaddy RE; Rossano JW
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28766759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
    Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
    Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossmatching technique facilitating kidney transplantation.
    Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
    Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
    Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
    Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
    Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.